Truist Securities Maintains Buy on Tractor Supply, Lowers Price Target to $246
Truist Securities analyst Scot Ciccarelli maintains Tractor Supply (NASDAQ:TSCO) with a Buy and lowers the price target from $266 to $246.
JP Morgan Maintains Underweight on Callon Petroleum, Lowers Price Target to $68
JP Morgan analyst Zach Parham maintains Callon Petroleum (NYSE:CPE) with a Underweight and lowers the price target from $75 to $68.
Tesla’s China Deliveries Climb To Record In June Amid Post-COVID Recovery: Report
U.S. electric vehicle giant Tesla, Inc. (NASDAQ: TSLA) reported record deliveries for June in China, as production ramped up following the COVID lockdowns.
Truist Securities Maintains Buy on F N B, Lowers Price Target to $13
Truist Securities analyst Brandon King maintains F N B (NYSE:FNB) with a Buy and lowers the price target from $16 to $13.
Eos Energy Enterprises, Inc. Announces Two New Orders With Bridgelink Commodities And A Northeast Solar Developer; Says Backlog Now Over $460M
Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos"), a leading provider of safe, scalable, efficient, and sustainable zinc-based energy storage systems, today announced the signing of two significant
Truist Securities Maintains Buy on Wintrust Finl, Lowers Price Target to $92
Truist Securities analyst Brandon King maintains Wintrust Finl (NASDAQ:WTFC) with a Buy and lowers the price target from $125 to $92.
Sheba Medical Center and Enlivex Announce Dosing Of The First Patient In Phase I/II Trial Evaluating Allocetra Combined With Chemotherapy In Patients With Peritoneal Metastases Arising From Solid Cancers
First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects in solid tumor models
Sheba Medical Center was
Truist Securities Maintains Buy on Seacoast Banking, Lowers Price Target to $39
Truist Securities analyst Brandon King maintains Seacoast Banking (NASDAQ:SBCF) with a Buy and lowers the price target from $42 to $39.
Deutsche Bank Maintains Buy on Sociedad Quimica Y Minera, Lowers Price Target to $105
Deutsche Bank analyst Corinne Blanchard maintains Sociedad Quimica Y Minera (NYSE:SQM) with a Buy and lowers the price target from $122 to $105.